• Official Full Name
  • melanoma antigen family B, 4
  • Background
  • This gene is a member of the MAGEB gene family. The members of this family have their entire coding sequences located in the last exon, and the encoded proteins show 50 to 68% sequence identity to each other. The promoters and first exons of the MAGEB genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEB genes are clustered on chromosome Xp22-p21. This gene sequence ends in the first intron of MAGEB1, another family member. This gene is expressed in testis.
  • Synonyms
  • MAGEB4; melanoma antigen family B, 4; melanoma-associated antigen B4; cancer/testis antigen family 3; member 6; CT3.6; melanoma associated antigen B4; MGC33144; MAGE-B4 antigen; cancer/testis antigen family 3, member 6
Source (Host):E. coliSpecies:Human
Product nameRecombinant Human MAGEB4, GST-tagged
Source (Host):Species:Human
Product nameRecombinant Human MAGEB4 293 Cell Lysate

Protein Function

MAGEB4 has several biochemical functions, for example, protein binding. Some of the functions are cooperated with other proteins, some of the functions could acted by MAGEB4 itself. We selected most functions MAGEB4 had, and list some proteins which have the same functions with MAGEB4. You can find most of the proteins on our site.
Related Protein
Function protein binding
Related Protein TAB1; NUP98; KLHL7; DBNL; CDC23; SGSM3; CD86; KCTD14; NACC2; CHCHD1

Interacting Protein

MAGEB4 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with MAGEB4 here. Most of them are supplied by our site. Hope this information will be useful for your research of MAGEB4.

MAGEB4 Related Articles

Melero, I; Hirschhorn-Cymerman, D; et al. Agonist Antibodies to TNFR Molecules That Costimulate T and NK Cells. CLINICAL CANCER RESEARCH 19:1044-1053(2013).
Mitsui, J; Nishikawa, H; et al. Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals. CLINICAL CANCER RESEARCH 16:2781-2791(2010).